While this is a common limitation in large public genomic cohorts, our findings are presented in the context of prostate cancer broadly, and future studies with more detailed pathological annotations may help refine the prognostic and mechanistic role of SLAMF8 across specific subtypes. The gene discussed is SLAMF8; the disease is prostate carcinoma.